D. Stave Kohtz

4.3k citations

50 papers · 3.7k indexed · 2 hit papers · h-index 23

Molecular Biology top 2%
Cell Biology top 0.5%
Physiology top 5%
Cardiology and Cardiovascular Medicine top 5%
Oncology top 10%

Co-authors: Caryn Chu Michael P. Lisanti Philipp E. Scherer Takashi Okamoto ZhaoLan Tang Kenneth Song Jeffrey A. Engelman Ikuo Nishimoto
Topics: Cancer-related Molecular Pathways (11 papers)Muscle Physiology and Disorders (9 papers)RNA Research and Splicing (8 papers)
Cited by: Cell Biology Molecular Biology Physiology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Clinical Investigation
Partner nations: United States Switzerland India

In The Last Decade

D. Stave Kohtz

50 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Cloning of Caveolin-3, a Novel Member of the Caveolin Gene Family Expressed Predominantly in Muscle

1996 603 citations ZhaoLan Tang, Philipp E. Scherer et al. Journal of Biological Chemistry profile →
Expression of Caveolin-3 in Skeletal, Cardiac, and Smooth Muscle Cells

1996 598 citations Kenneth Song, Philipp E. Scherer et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by D. Stave Kohtz

Since Specialization

Citations

This map shows the geographic impact of D. Stave Kohtz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Stave Kohtz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Stave Kohtz more than expected).

Fields of papers citing papers by D. Stave Kohtz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Stave Kohtz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Stave Kohtz. The network helps show where D. Stave Kohtz may publish in the future.

Co-authorship network of co-authors of D. Stave Kohtz

This figure shows the co-authorship network connecting the top 25 collaborators of D. Stave Kohtz. A scholar is included among the top collaborators of D. Stave Kohtz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Stave Kohtz. D. Stave Kohtz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Spheroid architecture strongly enhances miR-221/222 expression and promotes oxidative phosphorylation in an ovarian cancer cell line through a mechanism that includes restriction of miR-9 expression 2024 ·Molecular Biology Reports ·(unknown),(unknown),(unknown),D. Stave Kohtz	3
2	Curcumin Loaded Dendrimers Specifically Reduce Viability of Glioblastoma Cell Lines 2021 ·Molecules ·(unknown),Bhairavi Srinageshwar,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),D. Stave Kohtz,Douglas R. Swanson,Ajit Sharma,Gary Dunbar,Julien Rossignol	45
3	Alterations in Nuclear Pore Architecture Allow Cancer Cell Entry into or Exit from Drug-Resistant Dormancy 2011 ·American Journal Of Pathology ·Yayoi Kinoshita,Tamara Kalir,Jamal Rahaman,Peter Dottino,D. Stave Kohtz	31
4	Feasibility of immunocytochemical detection of tumor markers (XIAP, phosphohistone H1 and p63) in FNA cellblock samples from head and neck squamous cell carcinoma 2008 ·Diagnostic Cytopathology ·Maoxin Wu,(unknown),Li Gan,D. Stave Kohtz,Lanjing Zhang,Eric M. Genden,David Burstein	6
5	Immunodetection of GLUT1, p63 and phospho‐histone H1 in invasive head and neck squamous carcinoma: correlation of immunohistochemical staining patterns with keratinization 2006 ·Histopathology ·David Burstein,Chandandeep Nagi,D. Stave Kohtz,(unknown),(unknown)	17
6	Functional interaction of Purα with the Cdk2 moiety of cyclin A/Cdk2 2005 ·Biochemical and Biophysical Research Communications ·Hong Liu,Sharon Barr,Caryn Chu,D. Stave Kohtz,Yayoi Kinoshita,Edward M. Johnson	24
7	Ectopic expression of murine diphosphoinositol polyphosphate phosphohydrolase 1 attenuates signaling through the ERK1/2 pathway 2004 ·Cellular Signalling ·Caryn Chu,Daisy Alapat,(unknown),(unknown),David Burstein,Michael P. Lisanti,Stephen B. Shears,D. Stave Kohtz	16
8	Immunohistochemical visualization of histone H1 phosphorylation in squamous intraepithelial lesions of the gynecologic tract 2003 ·Human Pathology ·(unknown),Beverly Y. Wang,Tamara Kalir,Li Gan,Carol Bodian,(unknown),D. Stave Kohtz,David Burstein	6
9	Expression of p63 in papillary thyroid carcinoma and in Hashimoto’s thyroiditis: a pathobiologic link? 2003 ·Human Pathology ·Pamela D. Unger,(unknown),Beverly Y. Wang,Li Gan,D. Stave Kohtz,David Burstein	87
10	Monoclonal Antibody Specific for Histone H1 Phosphorylated by Cyclin-Dependent Kinases: A Novel Immunohistochemical Probe of Proliferation and Neoplasia 2002 ·Modern Pathology ·David Burstein,(unknown),Francine R. Dembitzer,Caryn Chu,(unknown),Anatoly Leytin,(unknown),(unknown),James A. Strauchen,D. Stave Kohtz	8
11	p63 In pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors 2002 ·Human Pathology ·Beverly Y. Wang,Joan Gil,David Kaufman,Li Gan,D. Stave Kohtz,David Burstein	150
12	Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. 1997 ·Journal of Clinical Investigation ·Alison D. Schecter,Peter L.A. Giesen,(unknown),Claire-Lise Rosenfield,Maria Rossikhina,Billie Fyfe,D. Stave Kohtz,John T. Fallon,Yale Nemerson,Mark B. Taubman	120
13	Cell-type and Tissue-specific Expression of Caveolin-2 1997 ·Journal of Biological Chemistry ·Philipp E. Scherer,Renée Y. Lewis,Daniela Volonté,Jeffrey A. Engelman,Ferruccio Galbiati,Jacques Couët,D. Stave Kohtz,Elly van Donselaar,Peter J. Peters,Michael P. Lisanti	462
14	Molecular Cloning of Caveolin-3, a Novel Member of the Caveolin Gene Family Expressed Predominantly in Musclebreakdown → 1996 ·Journal of Biological Chemistry ·ZhaoLan Tang,Philipp E. Scherer,Takashi Okamoto,Kenneth Song,Caryn Chu,D. Stave Kohtz,Ikuo Nishimoto,Harvey F. Lodish,Michael P. Lisanti	603
15	Positive and Negative Regulation of D-type Cyclin Expression in Skeletal Myoblasts by Basic Fibroblast Growth Factor and Transforming Growth Factor β 1995 ·Journal of Biological Chemistry ·(unknown),D. Stave Kohtz	117
16	Monoclonal antibodies identify a possible regulatory domain of MyoD1 1992 ·Journal of Cellular Biochemistry ·Francesca Cole,(unknown),D. Stave Kohtz	2
17	Novel proteins mediate an interaction between clathrin‐coated vesicles and polymerizing actin filaments 1990 ·European Journal of Biochemistry ·D. Stave Kohtz,Veneta Hanson,Saul Puszkin	12
18	Novel NGF‐induced proteins in PC12 cells: Immunological evidence for their presence in brain nerve endings using a single monoclonal antibody 1990 ·Journal of Neuroscience Research ·D. Stave Kohtz,Saul Puszkin	1
19	Phosphorylation of Tubulin by Casein Kinase II Regulates Its Binding to a Neuronal Protein (NP185) Associated with Brain Coated Vesicles 1989 ·Journal of Neurochemistry ·D. Stave Kohtz,Saul Puszkin	22
20	Isolation and characterization of monoclonal antibodies against ribonuclease inhibitor 1988 ·Biochemical and Biophysical Research Communications ·Mark Feldman,D. Stave Kohtz,David L. Kleinberg	7

About D. Stave Kohtz

D. Stave Kohtz is a scholar working on Cell Biology, Aging and Molecular Biology, having authored 50 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), Muscle Physiology and Disorders (9 papers) and RNA Research and Splicing (8 papers). The work is most often cited by research in Cell Biology (2.0k citations), Molecular Biology (2.6k citations) and Physiology (525 citations). D. Stave Kohtz has collaborated with scholars based in United States, Switzerland and India. Frequent co-authors include Caryn Chu, Michael P. Lisanti, Philipp E. Scherer, Takashi Okamoto, ZhaoLan Tang, Kenneth Song, Jeffrey A. Engelman, Ikuo Nishimoto, Harvey F. Lodish and Shengwen Calvin Li. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact